Diagnostic Consultation Center XX-Sofia EOOD
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Diagnostic Consultation Center XX-Sofia EOOD, cardiovascular research focuses on atrial fibrillation and the prevention of stroke and systemic embolism. These studies are designed to compare treatment options and better understand how to balance effectiveness with safety for people at risk of serious clot-related complications.
- Prevention of stroke and systemic embolism in atrial fibrillation
- Evaluating treatment effectiveness and bleeding risk in heart rhythm disorders
This area reflects a strong interest in improving care for patients with cardiovascular disease through safer and more effective long-term treatment choices.
Digestive System Diseases
Research in digestive system diseases centers on cholestasis and primary biliary cholangitis, with a focus on relieving cholestatic pruritus. The trials aim to assess whether new therapy options can improve comfort and support better symptom control over time.
- Cholestasis and cholestatic itching in primary biliary cholangitis
- Testing a new approach to improve symptom relief and long-term tolerability
This work highlights the site’s role in exploring treatments that may help people living with chronic liver and bile duct disorders.
Immune System Diseases
The site also conducts studies in immune system diseases, especially alopecia areata, an autoimmune condition that causes sudden hair loss. Research here is aimed at evaluating new therapies that may reduce symptoms and improve hair regrowth while maintaining safety in both adults and adolescents.
- Severe alopecia areata in adults and adolescents
- Assessing a potential treatment for symptom improvement and longer-term disease control
This therapeutic area shows a clear interest in autoimmune disease care and in finding better options for patients affected by visible, life-impacting conditions.
Nutritional and Metabolic Diseases
In the field of nutritional and metabolic diseases, research at this Sofia site includes severe hypertriglyceridemia. The clinical trials are focused on lowering very high triglyceride levels and evaluating whether new treatment approaches can improve metabolic health.
- Severe hypertriglyceridemia
- Studying a therapy intended to reduce triglycerides and support cardiovascular risk management
This area connects metabolic disorder research with broader efforts to prevent complications linked to abnormal blood fat levels.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 7 therapeutic areas and 15 of 34 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 12 by active trials.
- 1AstraZeneca AB5active
lock +11 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB10trials
lock +8 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diagnostic Consultation Center XX-Sofia EOOD
lock Showing 1 of 47 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics with Multiple Therapies in Participants with Active Crohn’s Disease or Active Ulcerative Colitis (ASCEND-IBD) | Mirador Therapeutics Inc. | Phase II | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 34 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 6 | Unknown | 2023-03-17 | 2026-07-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.